Jose L. Firvida - Publications

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer.

Journal: World journal of clinical oncology

Published: March 28, 2021

Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.

Journal: Current treatment options in oncology

Published: January 11, 2021

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report.

Journal: Frontiers in oncology

Published: July 02, 2019

Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer.

Journal: Anticancer research

Published: December 31, 2018

Geriatric oncology in Spain: survey results and analysis of the current situation.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 12, 2017

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10).

Journal: Cancer management and research

Published: February 20, 2016

Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.

Journal: Anticancer research

Published: April 03, 2014

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.

Journal: Anti-cancer drugs

Published: January 04, 2014

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.

Journal: Expert opinion on pharmacotherapy

Published: May 29, 2012